"gsk" - Google News

GSK’s $700M Alector bet blows up as Alzheimer’s drug flunks phase 2 - Fierce Biotech

Thu, 30 Apr 2026 09:15:00 GMT

GSK’s $700M Alector bet blows up as Alzheimer’s drug flunks phase 2 Fierce Biotech

MHRA approves GSK’s Lynavoy for the treatment of itch due to biliary tract disease - The Pharma Letter

Fri, 01 May 2026 17:35:42 GMT

MHRA approves GSK’s Lynavoy for the treatment of itch due to biliary tract disease The Pharma Letter

New GSK CEO’s first quarter boosted by Shingrix surge as Exdensur stumbles in switch trial - Fierce Pharma

Wed, 29 Apr 2026 14:47:13 GMT

New GSK CEO’s first quarter boosted by Shingrix surge as Exdensur stumbles in switch trial Fierce Pharma

Avalyn's upsized IPO; Alector ends another study in GSK partnership; Teva's $700M buy - Endpoints News

Thu, 30 Apr 2026 15:33:00 GMT

Avalyn's upsized IPO; Alector ends another study in GSK partnership; Teva's $700M buy Endpoints News

GSK Q1 Earnings Call Highlights - Yahoo Finance

Wed, 29 Apr 2026 12:37:30 GMT

GSK Q1 Earnings Call Highlights Yahoo Finance

GSK’s game of catch-up might just work - Financial Times

Wed, 29 Apr 2026 17:08:21 GMT

GSK’s game of catch-up might just work Financial Times

As GSK shares fall 5% on Q1 news, is this a buying opportunity? - Yahoo Finance UK

Wed, 29 Apr 2026 12:39:19 GMT

As GSK shares fall 5% on Q1 news, is this a buying opportunity? Yahoo Finance UK

GSK Q1 Earnings Beat Estimates, Specialty Medicines Drive Sales Growth - Yahoo Finance

Wed, 29 Apr 2026 14:29:00 GMT

GSK Q1 Earnings Beat Estimates, Specialty Medicines Drive Sales Growth Yahoo Finance

UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies - CNBC

Wed, 29 Apr 2026 09:32:51 GMT

UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies CNBC

GSK sees blockbuster potential in targeted cancer therapy after promising early data - Reuters

Mon, 13 Apr 2026 07:00:00 GMT

GSK sees blockbuster potential in targeted cancer therapy after promising early data Reuters

GSK delivers strong Q1 performance and start to 2026 - GSK

Thu, 30 Apr 2026 01:52:28 GMT

GSK delivers strong Q1 performance and start to 2026 GSK

GSK shares slide as investors question one-off result boost - Reuters

Wed, 29 Apr 2026 16:04:12 GMT

GSK shares slide as investors question one-off result boost Reuters

Which blockbuster is GSK gunning for next? CEO Miels is looking to oncology - Fierce Biotech

Wed, 29 Apr 2026 11:16:30 GMT

Which blockbuster is GSK gunning for next? CEO Miels is looking to oncology Fierce Biotech

Earnings call transcript: GSK Q1 2026 results miss expectations, stock drops - Investing.com

Wed, 29 Apr 2026 12:26:52 GMT

Earnings call transcript: GSK Q1 2026 results miss expectations, stock drops Investing.com

GSK Earnings: Strong Start to the Year Due to Specialty Medicines and Shingrix - Morningstar Canada

Thu, 30 Apr 2026 15:04:35 GMT

GSK Earnings: Strong Start to the Year Due to Specialty Medicines and Shingrix Morningstar Canada

How Gsk Plc American Depositary Shares (each Representing Two) (GSK) Affects Rotational Strategy Timing - Stock Traders Daily

Sat, 02 May 2026 12:44:01 GMT

How Gsk Plc American Depositary Shares (each Representing Two) (GSK) Affects Rotational Strategy Timing Stock Traders Daily

GSK’s Shingrix strategy shift drives sales beat even as vaccines slow - BioSpace

Wed, 29 Apr 2026 12:57:01 GMT

GSK’s Shingrix strategy shift drives sales beat even as vaccines slow BioSpace

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat - MarketBeat

Sat, 02 May 2026 13:37:17 GMT

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat MarketBeat

GSK's first quarter gets specialty meds, Shingrix boost - FirstWord Pharma

Wed, 29 Apr 2026 14:01:21 GMT

GSK's first quarter gets specialty meds, Shingrix boost FirstWord Pharma

GSK Earnings Boosted by Higher Specialty Medicine Sales - WSJ

Wed, 29 Apr 2026 06:45:00 GMT

GSK Earnings Boosted by Higher Specialty Medicine Sales WSJ

Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA - GSK

Tue, 28 Apr 2026 22:25:55 GMT

Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA GSK

GSK-partnered Alector hit with third neuro failure as Alzheimer’s asset disappoints - BioSpace

Thu, 30 Apr 2026 11:33:14 GMT

GSK-partnered Alector hit with third neuro failure as Alzheimer’s asset disappoints BioSpace

Spotlight On: GSK suggests Nucala is quickly challenging status-quo in US COPD market - FirstWord Pharma

Fri, 01 May 2026 15:20:31 GMT

Spotlight On: GSK suggests Nucala is quickly challenging status-quo in US COPD market FirstWord Pharma

GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH - GSK

Mon, 27 Apr 2026 23:54:30 GMT

GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH GSK

GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program - Fierce Biotech

Wed, 29 Apr 2026 10:16:17 GMT

GSK walks away from $100M bet on Mersana's STING ADC, pauses mRNA bird flu shot program Fierce Biotech

TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation - GSK

Mon, 27 Apr 2026 07:23:22 GMT

TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation GSK

GSK Canada secures priority review for regulatory submission of bepirovirsen, a potential functional cure treatment for chronic hepatitis B - Yahoo Finance

Thu, 30 Apr 2026 11:00:00 GMT

GSK Canada secures priority review for regulatory submission of bepirovirsen, a potential functional cure treatment for chronic hepatitis B Yahoo Finance

GSK (GSK) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance

Wed, 29 Apr 2026 11:10:02 GMT

GSK (GSK) Tops Q1 Earnings and Revenue Estimates Yahoo Finance

GSK Profit Beats Estimates on HIV, Cancer Medicines - Bloomberg.com

Wed, 29 Apr 2026 13:49:33 GMT

GSK Profit Beats Estimates on HIV, Cancer Medicines Bloomberg.com

GSK's Tesaro unit dealt pre-trial blow in Jemperli feud with AnaptysBio - Fierce Pharma

Tue, 28 Apr 2026 12:41:00 GMT

GSK's Tesaro unit dealt pre-trial blow in Jemperli feud with AnaptysBio Fierce Pharma

First-quarter sales strength buoys new GSK CEO Miels - pharmaphorum

Wed, 29 Apr 2026 10:50:03 GMT

First-quarter sales strength buoys new GSK CEO Miels pharmaphorum

Alector drops GSK-partnered Alzheimer’s drug (ALEC:NASDAQ) - Seeking Alpha

Thu, 30 Apr 2026 18:01:30 GMT

Alector drops GSK-partnered Alzheimer’s drug (ALEC:NASDAQ) Seeking Alpha

Oncology Drive Boosts London’s Biggest Pharma Firms Astra and GSK - Bloomberg.com

Wed, 29 Apr 2026 07:15:49 GMT

Oncology Drive Boosts London’s Biggest Pharma Firms Astra and GSK Bloomberg.com

Another miss for GSK, Alector after Phase II Alzheimer's trial halted - FirstWord Pharma

Thu, 30 Apr 2026 11:30:26 GMT

Another miss for GSK, Alector after Phase II Alzheimer's trial halted FirstWord Pharma

GSK posts Q1 beat and reaffirms outlook (GSK:NYSE) - Seeking Alpha

Wed, 29 Apr 2026 10:01:06 GMT

GSK posts Q1 beat and reaffirms outlook (GSK:NYSE) Seeking Alpha

Failure of GSK-partnered Alzheimer’s drug a fresh setback for Alector - The Pharma Letter

Fri, 01 May 2026 12:45:39 GMT

Failure of GSK-partnered Alzheimer’s drug a fresh setback for Alector The Pharma Letter

GSK beats quarterly profit estimates on strength in respiratory, general medicines - Yahoo

Wed, 29 Apr 2026 06:08:00 GMT

GSK beats quarterly profit estimates on strength in respiratory, general medicines Yahoo

GSK presents positive data for B7-H4-targeted ADC in gynecological cancers - GSK

Sun, 12 Apr 2026 07:00:00 GMT

GSK presents positive data for B7-H4-targeted ADC in gynecological cancers GSK

Roanne Parry Joins GSK as Chief People Officer - hrtoday.in

Sat, 02 May 2026 07:38:55 GMT

Roanne Parry Joins GSK as Chief People Officer hrtoday.in

GSK shares slide despite broadly positive quarter - The Pharma Letter

Wed, 29 Apr 2026 18:00:49 GMT

GSK shares slide despite broadly positive quarter The Pharma Letter

GSK (LSE: GSK) grows Q1 2026 core profit 10% CER, backs 2026 guidance - Stock Titan

Wed, 29 Apr 2026 12:09:42 GMT

GSK (LSE: GSK) grows Q1 2026 core profit 10% CER, backs 2026 guidance Stock Titan

GSK Q1 Earnings Call Highlights - MarketBeat

Wed, 29 Apr 2026 12:39:47 GMT

GSK Q1 Earnings Call Highlights MarketBeat

GSK (NYSE: GSK) details April 2026 total voting rights and share capital - Stock Titan

Fri, 01 May 2026 15:11:25 GMT

GSK (NYSE: GSK) details April 2026 total voting rights and share capital Stock Titan

GSK CEO says team reorg could be in the cards pending upcoming Phase 3 readouts - Endpoints News

Wed, 29 Apr 2026 11:22:00 GMT

GSK CEO says team reorg could be in the cards pending upcoming Phase 3 readouts Endpoints News

GSK Q1 2026 slides: specialty growth offsets earnings miss - Investing.com

Wed, 29 Apr 2026 12:59:00 GMT

GSK Q1 2026 slides: specialty growth offsets earnings miss Investing.com

Major holder in GSK (NYSE: GSK) reports 4.93% of voting rights - Stock Titan

Fri, 01 May 2026 15:08:31 GMT

Major holder in GSK (NYSE: GSK) reports 4.93% of voting rights Stock Titan

GSK announces recipients of Linked by Lupus: Optimal Care Initiative grants nearing $1 million - GSK

Tue, 20 Jan 2026 08:00:00 GMT

GSK announces recipients of Linked by Lupus: Optimal Care Initiative grants nearing $1 million GSK

Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale - Fierce Pharma

Fri, 17 Apr 2026 07:00:00 GMT

Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale Fierce Pharma

GSK’s overhaul undermined by decline from older medicines - MSN

Wed, 29 Apr 2026 11:53:22 GMT

GSK’s overhaul undermined by decline from older medicines MSN

GSK (NYSE: GSK) leaders report London share buy and ADS acquisition - Stock Titan

Wed, 29 Apr 2026 16:00:42 GMT

GSK (NYSE: GSK) leaders report London share buy and ADS acquisition Stock Titan

GSK profit beats on shingles vaccines and specialty drugs in new CEO’s first quarter - PharmaLive

Wed, 29 Apr 2026 06:10:00 GMT

GSK profit beats on shingles vaccines and specialty drugs in new CEO’s first quarter PharmaLive

GSK delivers strong 2025 performance and re-affirms long-term outlooks - GSK

Wed, 04 Feb 2026 08:00:00 GMT

GSK delivers strong 2025 performance and re-affirms long-term outlooks GSK

Strong vaccine sales deliver an early boost for GSK’s new boss - The Times

Wed, 29 Apr 2026 16:25:00 GMT

Strong vaccine sales deliver an early boost for GSK’s new boss The Times

Kepler Capital Remains a Hold on GlaxoSmithKline (GSK) - The Globe and Mail

Sat, 02 May 2026 02:00:00 GMT

Kepler Capital Remains a Hold on GlaxoSmithKline (GSK) The Globe and Mail

GSK enters agreement to acquire 35Pharma Inc. - GSK

Wed, 25 Feb 2026 08:00:00 GMT

GSK enters agreement to acquire 35Pharma Inc. GSK

GSK’s RSV vaccine, AREXVY, approved in US for expanded age indication in adults aged 18–49 years at increased risk - GSK

Fri, 13 Mar 2026 07:00:00 GMT

GSK’s RSV vaccine, AREXVY, approved in US for expanded age indication in adults aged 18–49 years at increased risk GSK

Why is everyone buying GSK shares? - Yahoo Finance UK

Fri, 17 Apr 2026 07:00:00 GMT

Why is everyone buying GSK shares? Yahoo Finance UK

GSK plc 2026 Q1 - Results - Earnings Call Presentation (NYSE:GSK) 2026-04-29 - Seeking Alpha

Wed, 29 Apr 2026 11:32:22 GMT

GSK plc 2026 Q1 - Results - Earnings Call Presentation (NYSE:GSK) 2026-04-29 Seeking Alpha

What's Going On With GSK Stock Wednesday? - GSK (NYSE:GSK) - Benzinga

Wed, 29 Apr 2026 10:59:59 GMT

What's Going On With GSK Stock Wednesday? - GSK (NYSE:GSK) Benzinga

GSK CEO's 'scientific courage' propels plans for medley of phase 3 trials for Hansoh-partnered ADC - Fierce Biotech

Sun, 12 Apr 2026 07:00:00 GMT

GSK CEO's 'scientific courage' propels plans for medley of phase 3 trials for Hansoh-partnered ADC Fierce Biotech

GSK (NYSE:GSK) Shares Gap Down - Should You Sell? - MarketBeat

Wed, 29 Apr 2026 17:24:26 GMT

GSK (NYSE:GSK) Shares Gap Down - Should You Sell? MarketBeat

Bombay HC backs GSK in Paxil trademark row against Shreya Life Sciences - The Economic Times

Sat, 02 May 2026 19:18:45 GMT

Bombay HC backs GSK in Paxil trademark row against Shreya Life Sciences The Economic Times

GSK | 5/1/26 - ktnv.com

Fri, 01 May 2026 17:20:00 GMT

GSK | 5/1/26 ktnv.com

Dodge & Cox discloses 4.93% stake in GSK as of April 28, filing says - marketscreener.com

Fri, 01 May 2026 14:09:53 GMT

Dodge & Cox discloses 4.93% stake in GSK as of April 28, filing says marketscreener.com

GSK Updates Market on Total Voting Rights and Share Capital - TipRanks

Fri, 01 May 2026 14:20:45 GMT

GSK Updates Market on Total Voting Rights and Share Capital TipRanks

GSK Beats Q1 Profit Estimates on Strong Respiratory Medicine Sales - Global Banking & Finance Review

Wed, 29 Apr 2026 08:48:23 GMT

GSK Beats Q1 Profit Estimates on Strong Respiratory Medicine Sales Global Banking & Finance Review

GSK stock price forecast: £2,000 support key as GSK trades flat - Traders Union

Mon, 27 Apr 2026 08:27:14 GMT

GSK stock price forecast: £2,000 support key as GSK trades flat Traders Union

GSK profit beats on shingles vaccines and specialty drugs in new CEO’s first quarter - WNWN-FM

Wed, 29 Apr 2026 11:17:27 GMT

GSK profit beats on shingles vaccines and specialty drugs in new CEO’s first quarter WNWN-FM

GSK awards $2M in COiMMUNITY Initiative grants to help close vaccination gaps, commits $3M for 2026 - GSK

Wed, 21 Jan 2026 08:00:00 GMT

GSK awards $2M in COiMMUNITY Initiative grants to help close vaccination gaps, commits $3M for 2026 GSK

GSK to invest $30 billion in R&D and Manufacturing in the United States over next 5 years - GSK

Wed, 17 Sep 2025 07:00:00 GMT

GSK to invest $30 billion in R&D and Manufacturing in the United States over next 5 years GSK

GSK (LON:GSK) Releases Quarterly Earnings Results - MarketBeat

Wed, 29 Apr 2026 16:00:33 GMT

GSK (LON:GSK) Releases Quarterly Earnings Results MarketBeat

Glaxo: Q1 Earnings Snapshot - KTVB

Wed, 29 Apr 2026 06:42:00 GMT

Glaxo: Q1 Earnings Snapshot KTVB

GSK profit beats on shingles vaccines and specialty drugs in new CEO's first quarter - MSN

Thu, 30 Apr 2026 04:04:55 GMT

GSK profit beats on shingles vaccines and specialty drugs in new CEO's first quarter MSN

GSK reports promising early results in ovarian and womb cancer drug trial - The Guardian

Sun, 12 Apr 2026 07:00:00 GMT

GSK reports promising early results in ovarian and womb cancer drug trial The Guardian

Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment - GSK

Mon, 20 Oct 2025 07:00:00 GMT

Global Fund welcomes renewed commitment from GSK and ViiV Healthcare to expand community-led health solutions with £6 million joint pledge ahead of 8th Replenishment GSK

GSK Reports Strong Q1 2026 Results with Revenue Growth - GuruFocus

Wed, 29 Apr 2026 12:07:13 GMT

GSK Reports Strong Q1 2026 Results with Revenue Growth GuruFocus

Luke Miels appointed CEO designate for GSK - GSK

Mon, 29 Sep 2025 07:00:00 GMT

Luke Miels appointed CEO designate for GSK GSK

GSK: 'Strong Buy' On Mo-Rez Oncology Expansion Potential (NYSE:GSK) - Seeking Alpha

Sun, 19 Apr 2026 07:00:00 GMT

GSK: 'Strong Buy' On Mo-Rez Oncology Expansion Potential (NYSE:GSK) Seeking Alpha

GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans - GSK

Fri, 19 Dec 2025 08:00:00 GMT

GSK enters agreement with U.S. government to lower drug prices and expand access to respiratory medicines for millions of Americans GSK

Antibody-drug conjugates: Advancing the search for more targeted cancer treatment - GSK

Fri, 10 Apr 2026 07:00:00 GMT

Antibody-drug conjugates: Advancing the search for more targeted cancer treatment GSK

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma - GSK

Thu, 23 Oct 2025 07:00:00 GMT

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma GSK

GSK Faces Setback as Nivisnebart Trial for Alzheimer's Discontin - GuruFocus

Wed, 29 Apr 2026 22:53:25 GMT

GSK Faces Setback as Nivisnebart Trial for Alzheimer's Discontin GuruFocus

Cancer drug licensed by GSK from China posts promising trial results - Financial Times

Sun, 12 Apr 2026 07:00:00 GMT

Cancer drug licensed by GSK from China posts promising trial results Financial Times

Shot in the arm for GSK and AstraZeneca from cancer drug sales - The Independent

Wed, 29 Apr 2026 11:21:00 GMT

Shot in the arm for GSK and AstraZeneca from cancer drug sales The Independent

GSK tops Q1 profit estimates on legal gains; shares slide on 2026 outlook - Investing.com

Wed, 29 Apr 2026 07:25:41 GMT

GSK tops Q1 profit estimates on legal gains; shares slide on 2026 outlook Investing.com

GSK’s Big Q1 Beat Came From Shingrix Stocking, Not Its Pipeline - Finimize

Wed, 29 Apr 2026 11:59:13 GMT

GSK’s Big Q1 Beat Came From Shingrix Stocking, Not Its Pipeline Finimize

GSK Reports Strong Q1 Sales Growth and Advancements in R&D - GuruFocus

Wed, 29 Apr 2026 10:57:14 GMT

GSK Reports Strong Q1 Sales Growth and Advancements in R&D GuruFocus

GSK Respiratory Breakthrough And Pipeline Advances Reshape Long Term Outlook - Yahoo Finance

Sun, 19 Apr 2026 07:00:00 GMT

GSK Respiratory Breakthrough And Pipeline Advances Reshape Long Term Outlook Yahoo Finance

GSK posts Q1 beat as HIV and cancer drugs offset weakness in general medicines - MSN

Wed, 29 Apr 2026 11:08:46 GMT

GSK posts Q1 beat as HIV and cancer drugs offset weakness in general medicines MSN

GSK Celebrates 2025 IMPACT Award Winners - GSK

Tue, 11 Nov 2025 08:00:00 GMT

GSK Celebrates 2025 IMPACT Award Winners GSK

GSK Reports Strong Q1 Earnings with EPS of £0.465, Revenue of £7 - GuruFocus

Wed, 29 Apr 2026 08:12:53 GMT

GSK Reports Strong Q1 Earnings with EPS of £0.465, Revenue of £7 GuruFocus

GSK and Fleming Initiative scientists unite to target AMR with advanced AI - GSK

Tue, 18 Nov 2025 08:00:00 GMT

GSK and Fleming Initiative scientists unite to target AMR with advanced AI GSK

GSK to Report Q1 Earnings with Strong Revenue Expectations - GuruFocus

Tue, 28 Apr 2026 17:32:17 GMT

GSK to Report Q1 Earnings with Strong Revenue Expectations GuruFocus

GSK delivers strong Q3 performance and upgrades 2025 guidance - GSK

Wed, 29 Oct 2025 07:00:00 GMT

GSK delivers strong Q3 performance and upgrades 2025 guidance GSK

GSK again pulls application for leucovorin, touted by FDA as potential autism treatment - BioSpace

Fri, 10 Apr 2026 07:00:00 GMT

GSK again pulls application for leucovorin, touted by FDA as potential autism treatment BioSpace

GSK Q1 Core Earnings, Sales Increase; 2026 Core EPS, Sales Outlook Maintained - marketscreener.com

Wed, 29 Apr 2026 07:36:30 GMT

GSK Q1 Core Earnings, Sales Increase; 2026 Core EPS, Sales Outlook Maintained marketscreener.com

GSK announces positive outcomes from Phase I BEHOLD-1 trial of Mo-Rez - Clinical Trials Arena

Mon, 13 Apr 2026 07:00:00 GMT

GSK announces positive outcomes from Phase I BEHOLD-1 trial of Mo-Rez Clinical Trials Arena

GSK and Empirico enter license agreement for clinical-stage, first-in-class oligonucleotide candidate to treat respiratory diseases - GSK

Tue, 28 Oct 2025 07:00:00 GMT

GSK and Empirico enter license agreement for clinical-stage, first-in-class oligonucleotide candidate to treat respiratory diseases GSK

New local data in GSK and IQVIA's Vaccine Track supports smarter public health action at the community level - GSK

Wed, 01 Oct 2025 07:00:00 GMT

New local data in GSK and IQVIA's Vaccine Track supports smarter public health action at the community level GSK

GSK to buy 35Pharma for $950 million in CEO Miel's second major deal - Reuters

Thu, 26 Feb 2026 08:00:00 GMT

GSK to buy 35Pharma for $950 million in CEO Miel's second major deal Reuters